About
Careers
News
Contact
Join Our Community
Login
Menu
About
Careers
News
Contact
Join Our Community
Login
Home
Therapeutic Areas
Age-Related Diseases
Anti-Infectives
Immunology & Inflammation
Kidney Diseases
Metabolic Disease & Complications
Neuroscience
Oncology
Rare Diseases
Respiratory
Women’s Health
Scientific Topics
ADME/DMPK
Biologics
Clinical Development
Formulation & CMC
Hit & Target ID/Validation
IND Enabling Studies/Preclinical Development
In vitro Biology
In vivo Pharmacology
Medicinal Chemistry
Modelling and Simulation
Proteomics, Metabolomics & Biomarkers
Sample Management
Structural Biology & Protein Science
Toxicology & Safety
Events
Blog
Home
Therapeutic Areas
Age-Related Diseases
Anti-Infectives
Immunology & Inflammation
Kidney Diseases
Metabolic Disease & Complications
Neuroscience
Oncology
Rare Diseases
Respiratory
Women’s Health
Scientific Topics
ADME/DMPK
Biologics
Clinical Development
Formulation & CMC
Hit & Target ID/Validation
IND Enabling Studies/Preclinical Development
In vitro Biology
In vivo Pharmacology
Medicinal Chemistry
Modelling and Simulation
Proteomics, Metabolomics & Biomarkers
Sample Management
Structural Biology & Protein Science
Toxicology & Safety
Events
Blog
Search
Search
Science Pool
Ask an Expert
Translation to the Clinic of EVT801. A Novel Immune-Oncology Agent
24 February 2021
Resource Type:
Oncology
,
Posters
DOWNLOAD
Home
Therapeutic areas
Age-Related Diseases
Anti-Infectives
Immunology & Inflammation
Kidney Diseases
Metabolic Disease & Complications
Neuroscience
Oncology
Rare Diseases
Respiratory
Women’s Health
Scientific Topics
ADME/DMPK
Biologics
Compound Management
Formulation & CMC
Hit & Target ID/Validation
Medicinal Chemistry
IND Enabling Studies/Preclinical Development
In vitro Biology
In vivo Pharmacology
Proteomics, Metabolomics & Biomarkers
Structural Biology & Protein Science
Toxicology & Safety
Blog
News
Events
About
Careers
Contact
Join Our Community
Email
Password
Remember me
Remember me
Login
